Association of severity of COPD with IgE and interleukin-1beta

Submitted: January 19, 2016
Accepted: January 19, 2016
Published: January 19, 2016
Abstract Views: 1431
PDF: 884
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Background. Chronic obstructive pulmonary disease (COPD) is a pulmonary inflammatory disease characterised by airflow limitation. The role of various inflammatory mediators such as interleukin-1beta (IL-1β) and Immunoglobulin E (IgE) have been implicated in COPD. In present study we aimed to establish if there is an association between the serum levels of IL-1β and IgE and the severity of airway obstruction. Materials and methods. The study group comprised of 30 non atopic smokers, suffering from COPD and 30 non smoker, healthy controls. Serum levels of IgE and IL-1β were assayed by ELISA in all subjects along with their pulmonary function tests. Results. Serum IgE and IL-1β levels were significantly raised in COPD patients as compared to healthy controls. IL-1β was negatively correlated with FEV1 (r=-0.624, p=0.003) and IgE showed a negative correlation with FVC (r=-0.477, p=0.034). Conclusion. Our study suggests that in COPD IL-1β and IgE serum levels correlate with clinical aspects of disease severity. We suggest that the production of IgE and IL-1β in the airways of patients with COPD may be related to smoking which affects airway obstruction.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Singh, B., S. Arora, and V. Khanna. 2016. “Association of Severity of COPD With IgE and Interleukin-1beta”. Monaldi Archives for Chest Disease 73 (2). https://doi.org/10.4081/monaldi.2010.303.